AIXTRON SE (ETR:AIXA)
13.63
+0.36 (2.67%)
Aug 8, 2025, 5:35 PM CET
Revance Therapeutics Market Cap
AIXTRON SE has a market cap or net worth of €1.54 billion as of August 8, 2025. Its market cap has decreased by -35.91% in one year.
Market Cap
1.54B
Enterprise Value
1.43B
Revenue
633.02M
Ranking
n/a
PE Ratio
14.20
Stock Price
$13.63
Market Cap Chart
Since May 21, 1998, AIXTRON SE's market cap has increased from 908.92M to 1.54B, an increase of 68.96%. That is a compound annual growth rate of 1.94%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 8, 2025 | 1.54B | -10.37% |
Dec 30, 2024 | 1.71B | -60.56% |
Dec 29, 2023 | 4.34B | 43.69% |
Dec 30, 2022 | 3.02B | 50.92% |
Dec 30, 2021 | 2.00B | 25.58% |
Dec 30, 2020 | 1.60B | 67.27% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 289.81B |
Infineon Technologies AG | 45.87B |
Nemetschek SE | 15.44B |
IONOS Group SE | 5.55B |
Bechtle AG | 4.41B |
ATOSS Software SE | 1.80B |
Kontron AG | 1.56B |
Elmos Semiconductor SE | 1.53B |